ESTRO 2024 - Abstract Book

S54 ESTRO 2024 In view of a harmonization of the level of education and training at European level and the recognition of MPE as health profession, EFOMP together with ESTRO, EANM, and ESR are investigating the possibility of developing a single combined CC for all three disciplines of Medical Physics with a general part common to all disciplines and discipline related specific parts, once the CC for MPE in Nuclear Medicine and in Radiology are updated. In this way, a framework for the education and training of MPE will be defined at European level including the minimum requirements to access the education and training, and the minimum duration to obtain the competences (CanMEDS roles) to become an independent specialist. Developing a unique core curriculum for MPEs is an urgent need for those European countries that have training schemes including the three disciplines which are the majority. This requirement is in line with the guidelines on MPE RP174 and will also facilitate the harmonization of the profession across Europe. Invited Speaker

3367

Integrating radiopharmaceuticals in cancer care

Joe M O'Sullivan

Queen's University Belfast, Patrick G Johnston Centre for Cancer Research, Belfast, United Kingdom

Abstract:

Radionuclide therapy is showing increasing promise in the treatment of advanced solid malignancy. Using the example of prostate cancer, I will discuss the clinical application of radionuclide therapy and postulate on future changes needed in healthcare delivery and regulation to facilitate the optimisation of these therapies for patient benefit.

3368

Intimacy, sexuality and emotions after cancer treatment: Addressing unmet needs

Vicky Lehmann

Amsterdam University Medical Center/ University of Amsterdam, Department of Medical Psychology, Amsterdam, Netherlands

Abstract:

Background : Cancer, its treatment, and side effects can cause various sexual problems (e.g., decreased interest, arousal problems, feelings of unattractiveness, pain, vaginal dryness, erectile dysfunction) all contributing to impaired sexual functioning and impaired quality of life (QoL). Such problems and care needs remain poorly understood and under-addressed in clinical practice, particularly for patients diagnosed during adolescence and young adulthood (AYAs). Intimacy and sexuality are topics of concern for young patients and survivors, as they can struggle to navigate (online) dating, relationship formation, changed body experiences, and feelings of guilt or inferiority towards a partner (e.g., due to infertility). Regaining one’s sexuality during and after cancer treatment can be a daunting task, especially if (radiation) radiation therapy involves primary and secondary sexual organs.